{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:03:35Z","timestamp":1784347415091,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106797","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:49:15Z","timestamp":1760546955000},"page":"106797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vitamin supplementation in the treatment of optic neuritis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6160-9328","authenticated-orcid":false,"given":"Patrick J.","family":"Gaffney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106797_bib0009","first-page":"281","article-title":"Chapter 12: pathophysiology of optic neuritis. Multiple sclerosis: a mechanistic view","author":"Al-Louzi","year":"2016","journal-title":"Alireza Minagar"},{"issue":"3","key":"10.1016\/j.msard.2025.106797_bib0041","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMa Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106797_bib0014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","article-title":"Optic neuritis treatment trial. One-year follow-up results","volume":"111","author":"Beck","year":"1993","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.msard.2025.106797_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Optic Neuritis Study Group. Visual function >10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"137","author":"Beck","year":"2004","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.msard.2025.106797_bib0013","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jnnp-2014-308185","article-title":"Re-evaluating the treatment of acute optic neuritis","volume":"86","author":"Bennett","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.msard.2025.106797_bib0006","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","article-title":"Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease","volume":"77","author":"Braithwaite","year":"2020","journal-title":"JAMa Neurol."},{"issue":"79\u201380","key":"10.1016\/j.msard.2025.106797_bib0005","first-page":"58","article-title":"How to test for a relative afferent pupillary defect (RAPD)","volume":"25","author":"Broadway","year":"2012","journal-title":"Community Eye Health"},{"issue":"6","key":"10.1016\/j.msard.2025.106797_bib0032","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ophtha.2006.08.046","article-title":"Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT","volume":"114","author":"Budenz","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.msard.2025.106797_bib0066","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1352458516642315","article-title":"A prospective cohort study of vitamin D in optic neuritis recovery","volume":"23","author":"Burton","year":"2017","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0047","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/brain\/awad409","article-title":"Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome","volume":"147","author":"Butzkueven","year":"2024","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.msard.2025.106797_bib0057","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3390\/antiox11122422","article-title":"Vitamin B3 provides neuroprotection via antioxidative stress in a rat model of anterior ischemic optic neuropathy","volume":"11","author":"Chen","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.msard.2025.106797_bib0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajo.2023.02.013","article-title":"Visual outcomes following plasma exchange for optic neuritis: an international multicenter retrospective analysis of 395 optic neuritis attacks","volume":"252","author":"Chen","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0037","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10384-012-0137-4","article-title":"Foveal sensitivity and visual acuity in macular thickening disorders","volume":"56","author":"Chiba","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.msard.2025.106797_bib0031","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-012-0166-2","article-title":"Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial","volume":"113","author":"Derakhshandi","year":"2013","journal-title":"Acta Neurol. Belg."},{"issue":"5","key":"10.1016\/j.msard.2025.106797_bib0022","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00415-016-8073-8","article-title":"Plasma exchange response in 34 patients with severe optic neuritis","volume":"263","author":"Deschamps","year":"2016","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106797_bib0001","first-page":"182","article-title":"Optic neuritis","volume":"5","author":"Dooley","year":"2010","journal-title":"J. Ophthalmic. Vis. Res."},{"key":"10.1016\/j.msard.2025.106797_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105564","article-title":"The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: a critical, systematic review and metaanalysis of randomized controlled trials","volume":"187","author":"Doosti-Irani","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112117","article-title":"Vitamin D exerts endogenous control over TH2 cell fate and immune plasticity","volume":"28","author":"Fangal","year":"2025","journal-title":"iScience"},{"issue":"24","key":"10.1016\/j.msard.2025.106797_bib0069","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.3390\/jcm11247278","article-title":"Vitamin D supplementation practices among multiple sclerosis patients and professionals","volume":"11","author":"Galus","year":"2022","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.msard.2025.106797_bib0046","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3390\/nu15061465","article-title":"Radiological benefits of vitamin D status and supplementation in patients with MS-A two-year prospective observational cohort study","volume":"15","author":"Galus","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.msard.2025.106797_bib0068","article-title":"Impact of vitamin D supplementation on multiple sclerosis","volume":"13","author":"Gandhi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.msard.2025.106797_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.796933","article-title":"Vitamin D as a risk factor for Multiple sclerosis: immunoregulatory or neuroprotective?","volume":"13","author":"Gombash","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106797_bib0026","first-page":"e1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell. Syst. Rev."},{"issue":"5","key":"10.1016\/j.msard.2025.106797_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15754","article-title":"Association between vitamin D deficiency and multiple sclerosis- MRI significance: a scoping review","volume":"9","author":"Hajeer","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0059","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00394-019-02014-4","article-title":"Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: analysis of data from the Japan Diabetes Complications Study (JDCS)","volume":"59","author":"Horikawa","year":"2020","journal-title":"Eur. J. Nutr."},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0011","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10072-014-1982-3","article-title":"Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning","volume":"36","author":"Huang-Link","year":"2015","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2025.106797_bib0036","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ophtha.2011.03.019","article-title":"Assessment of visual function in glaucoma: a report by the American Academy of Ophthalmology","volume":"118","author":"Jampel","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.msard.2025.106797_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(99)00002-6","article-title":"Diagnosis and pathogenesis of glaucomatous optic neuropathy: morphological aspects","volume":"19","author":"Jonas","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200067","article-title":"Treatment with erythropoietin for patients with optic neuritis: long-term follow-up","volume":"10","author":"K\u00fcchlin","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2025.106797_bib0017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.50.1.230","article-title":"Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis","volume":"50","author":"Kapoor","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2025.106797_bib0039","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1756285617708911","article-title":"MRI in the assessment and monitoring of multiple sclerosis: an update on best practice","volume":"10","author":"Kaunzner","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"6","key":"10.1016\/j.msard.2025.106797_bib0051","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/ceo.12308","article-title":"Retinoic acid receptor stimulation ameliorates experimental autoimmune optic neuritis","volume":"43","author":"Keino","year":"2015","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.msard.2025.106797_bib0004","article-title":"Severe bilateral optic neuritis: a rare presentation of clinically isolated syndrome","volume":"12","author":"Khetpal","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.msard.2025.106797_bib0012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/eye.2016.253","article-title":"Retinal ganglion cell and axonal loss in optic neuritis: risk factors and visual functions","volume":"31","author":"Lee","year":"2017","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0064","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jnr.10491","article-title":"Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line","volume":"71","author":"Lefebvre d'Hellencourt","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2025.106797_bib0003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.preteyeres.2013.03.001","article-title":"Optic neuritis in neuromyelitis optica","volume":"36","author":"Levin","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.msard.2025.106797_bib0029","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5582\/ddt.2020.03031","article-title":"High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study","volume":"14","author":"Mallone","year":"2020","journal-title":"Drug Discov. Ther."},{"issue":"3","key":"10.1016\/j.msard.2025.106797_bib0062","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0091-6749(03)01855-4","article-title":"Dual effects of vitamin d-induced alteration of TH1\/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease","volume":"112","author":"Matheu","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.msard.2025.106797_bib0016","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/0301-4738.33821","article-title":"Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis","volume":"55","author":"Menon","year":"2007","journal-title":"Indian J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.msard.2025.106797_bib0020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jamaneurol.2018.0024","article-title":"Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial","volume":"75","author":"Morrow","year":"2018","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106797_bib0054","first-page":"11","article-title":"The effects of All-Trans Retinoic Acid on clinical symptoms, nitric oxide levels and total antioxidant capacity of plasma in mouse model of multiple sclerosis","volume":"20","author":"Morvaridi","year":"2013","journal-title":"Razi J. Med. Sci."},{"issue":"5835","key":"10.1016\/j.msard.2025.106797_bib0052","first-page":"256","article-title":"Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid","volume":"317","author":"Mucida","year":"2007","journal-title":"Science 1979"},{"issue":"1","key":"10.1016\/j.msard.2025.106797_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2025.106797_bib0023","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","article-title":"A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis","volume":"56","author":"Noseworthy","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2025.106797_bib0002","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2025.106797_bib0008","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/eye.2011.81","article-title":"Optic neuritis","volume":"25","author":"Pau","year":"2011","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.msard.2025.106797_bib0034","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/eye.2015.60","article-title":"The Eye Phone Study: reliability and accuracy of assessing Snellen visual acuity using smartphone technology","volume":"29","author":"Perera","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.msard.2025.106797_bib0065","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.2147\/OPTH.S383703","article-title":"Serum vitamin D levels and status in Thai optic neuritis subjects: a case-control study","volume":"16","author":"Puangsricharoen","year":"2022","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.msard.2025.106797_bib0028","first-page":"23","article-title":"Effect of vitamin A on recovery from the acute phase of multiple sclerosis-related optic neuritis, double-blind, randomized, placebo-controlled trial","volume":"14","author":"Rahimi-Dehgolan","year":"2023","journal-title":"Caspian. J. Intern. Med."},{"key":"10.1016\/j.msard.2025.106797_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102132","article-title":"The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder","volume":"42","author":"Rezaeimanesh","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2025.106797_bib0024","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","article-title":"A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis","volume":"64","author":"Roed","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/1735-1995.158266","article-title":"Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: preliminary findings of a randomized, placebo-controlled trial","volume":"20","author":"Salari","year":"2015","journal-title":"J. Res. Med. Sci."},{"issue":"2","key":"10.1016\/j.msard.2025.106797_bib0049","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.msard.2015.01.005","article-title":"High doses of biotin in chronic progressive multiple sclerosis: a pilot study","volume":"4","author":"Sedel","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2025.106797_bib0019","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","article-title":"A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"52","author":"Sellebjerg","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106797_bib0060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuroscience.2024.09.042","article-title":"Vitamin D: the crucial neuroprotective factor for nerve cells","volume":"560","author":"Shi","year":"2024","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.msard.2025.106797_bib0043","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and Multiple sclerosis: a comprehensive review","volume":"7","author":"Sintzel","year":"2018","journal-title":"Neurol. Ther."},{"issue":"3","key":"10.1016\/j.msard.2025.106797_bib0038","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.optom.2018.08.001","article-title":"Comparison of macular retinal sensitivity and its contribution to the foveal sensitivity between diabetic and non-diabetic patients with normal visual acuity","volume":"12","author":"Somilleda-Ventura","year":"2019","journal-title":"J. Optom."},{"issue":"16","key":"10.1016\/j.msard.2025.106797_bib0048","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis: the D-lay MS randomized clinical trial","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMa"},{"issue":"7","key":"10.1016\/j.msard.2025.106797_bib0027","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40263-018-0528-2","article-title":"MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the treatment of chronic visual loss related to optic neuritis in multiple sclerosis: a randomized, double-blind, placebo-controlled study","volume":"32","author":"Tourbah","year":"2018","journal-title":"CNS. Drugs"},{"issue":"2","key":"10.1016\/j.msard.2025.106797_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-5155(98)00071-9","article-title":"Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic neuritis treatment Trial Multicenter Cooperative Research Group (ONMRG)","volume":"43","author":"Wakakura","year":"1999","journal-title":"Jpn. J. Ophthalmol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106797_bib0056","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(02)02587-8","article-title":"Vitamin B6 protects primate retinal neurons from ischemic injury","volume":"940","author":"Wang","year":"2002","journal-title":"Brain Res."},{"issue":"14","key":"10.1016\/j.msard.2025.106797_bib0007","doi-asserted-by":"crossref","first-page":"E2029","DOI":"10.1073\/pnas.1520113113","article-title":"Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.msard.2025.106797_bib0053","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","article-title":"Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression","volume":"181","author":"Xiao","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.msard.2025.106797_bib0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/1028415X.2001.11747375","article-title":"Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys","volume":"4","author":"Yamashima","year":"2001","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.msard.2025.106797_bib0058","article-title":"Higher vitamin B6 dietary consumption is associated with a lower risk of glaucoma among United States adults","volume":"11","author":"Yang","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.msard.2025.106797_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/694613","article-title":"Prospective study on retinal nerve fibre layer thickness changes in isolated unilateral retrobulbar optic neuritis","volume":"2013","author":"Yau","year":"2013","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.msard.2025.106797_bib0044","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.msard.2018.05.008","article-title":"The efficacy of vitamin D in multiple sclerosis: a meta-analysis","volume":"23","author":"Zheng","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2025.106797_bib0067","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4103\/1673-5374.335139","article-title":"Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?","volume":"17","author":"Zorzella-Pezavento","year":"2022","journal-title":"Neural Regen. Res."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:33:34Z","timestamp":1784345614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":68,"alternative-id":["S2211034825005395"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106797","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin supplementation in the treatment of optic neuritis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106797"}}